Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

This repository is under review for potential modification in compliance with Administration directives.

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

Condition

Iritis

43

Unknown

2,596

Pain

619

Cancer

609

Hypertension

575

All Match

Any Match

Exclude Selected

Exclude Selected

Development Status

US Approved Rx

43

All Match

Any Match

Exclude Selected

Exclude Selected

Primary Target

Glucocorticoid receptor

43

Glucocorticoid and meneralocorticoid receptor agonists/antagonists

22

Mineralocorticoid receptor

21

All Match

Any Match

Exclude Selected

Exclude Selected

Highest Phase

Approved

43

All Match

Any Match

Exclude Selected

Exclude Selected

Approval Year

1955

22

1958

21

All Match

Any Match

Exclude Selected

Exclude Selected

Treatment Modality

Primary

43

Curative

22

Palliative

22

All Match

Any Match

Exclude Selected

Exclude Selected

CNS Activity

CNS Active

22

CNS Penetrant

21

All Match

Any Match

Exclude Selected

Exclude Selected

Originator

Merck

22

Arth, G.E. et al.

21

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Class

Chemical

42

Mixture

1

All Match

Any Match

Exclude Selected

Exclude Selected

Code System

FDA UNII

43

CAS

42

PUBCHEM

42

EPA CompTox

39

SMS_ID

36

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 1

ALIMENTARY TRACT AND METABOLISM

3

SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS

3

CARDIOVASCULAR SYSTEM

2

DERMATOLOGICALS

2

RESPIRATORY SYSTEM

2

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 2

CORTICOSTEROIDS FOR SYSTEMIC USE

3

ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS

2

CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS

2

NASAL PREPARATIONS

2

OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS

2

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 3

CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN

3

AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE

2

ANTIINFLAMMATORY AGENTS

2

ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION

2

CORTICOSTEROIDS

2

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 4

Glucocorticoids

3

Corticosteroids

2

Corticosteroids acting locally

2

Corticosteroids and antiinfectives in combination

2

Corticosteroids for local oral treatment

2

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Form

Salts, Hydrates, Esters, etc.

41

Principal Form

2

All Match

Any Match

Exclude Selected

Exclude Selected

Showing 1 - 10 of 43 results

First page disabled
Previous page disabled
1
Next page
Next page

DEXAMETHASONE

7S5I7G3JQL

Export Data
Search for Structure

Status:

US Approved Rx (2018)

First approved in 1958

Class (Stereo):

CHEMICAL (ABSOLUTE)

Targets:

Glucocorticoid receptor

Mineralocorticoid receptor

Glucocorticoid receptor

Conditions:

Multiple myeloma

Herpes zoster keratitis

Allergic conjunctivitis

Superficial punctate keratitis

Bacterial conjunctivitis

Dexamethasone is an anti-inflammatory agent that is FDA approved for the treatment of many conditions, including rheumatic problems, a number of skin diseases, severe allergies, asthma, chronic obstructive lung disease, croup, brain swelling and othe...

rs. Dexamethasone is a glucocorticoid agonist. Unbound dexamethasone crosses cell membranes and binds with high affinity to specific cytoplasmic glucocorticoid receptors. Adverse reactions are: Glaucoma with optic nerve damage, visual acuity and field defects; cataract formation; secondary ocular infection following suppression of host response; and perforation of the globe may occur; muscle weakness; osteoporosis and others. Aminoglutethimide may diminish adrenal suppression by corticosteroids. Macrolide antibiotics have been reported to cause a significant decrease in corticosteroid clearance.

Prednisolone

9PHQ9Y1OLM

Export Data
Search for Structure

Status:

US Approved Rx (2010)

First approved in 1955

Class (Stereo):

CHEMICAL (ABSOLUTE)

Targets:

Glucocorticoid receptor

Glucocorticoid receptor

Glucocorticoid receptor

Glucocorticoid receptor

Glucocorticoid receptor

Glucocorticoid and meneralocorticoid receptor agonists/antagonists

Conditions:

Inflammation and pain

Atopic dermatitis

Severe erythema multiforme (Stevens-Johnson syndrome)

Crohn's disease

Congenital adrenal hyperplasia

Aggressive lymphoma

Diamond-Blackfan anemia

Primary or secondary adrenocortical insufficiency

Rheumatic diseases

Allergic states

Mycosis fungoides

Multiple sclerosis

Hematologic disorders

Symptomatic sarcoidosis

Herpes zoster keratitis

Superficial punctate keratitis

Allergic conjunctivitis

Acute asthma attack

Pulmonary edema

Rheumatoid arthritis

Prednisolone hemisuccinate is a prodrug of a glucocorticoid agonist prednisolone, which is marketed under trade name Prednisolut in Germany and Austria. Prednisolone hemisuccinate is used in emergency medicine to treate shock due to allergic reaction...

, insect and snake bites, in neurology to treat brain edema and meningitis, in transplantation medicine to reduce risk of organ refection after kidney transplane, in pneumology to treat acute asthma attack, pulmonary edema, in severe or life-threatening situation in rheumatic diseases.

Dexamethasone 21-sulfate

VMN9Z37FQR

Export Data
Search for Structure

Status:

US Approved Rx (2018)

First approved in 1958

Class (Stereo):

CHEMICAL (ABSOLUTE)

Targets:

Glucocorticoid receptor

Mineralocorticoid receptor

Glucocorticoid receptor

Conditions:

Multiple myeloma

Herpes zoster keratitis

Allergic conjunctivitis

Superficial punctate keratitis

Bacterial conjunctivitis

Dexamethasone is an anti-inflammatory agent that is FDA approved for the treatment of many conditions, including rheumatic problems, a number of skin diseases, severe allergies, asthma, chronic obstructive lung disease, croup, brain swelling and othe...

rs. Dexamethasone is a glucocorticoid agonist. Unbound dexamethasone crosses cell membranes and binds with high affinity to specific cytoplasmic glucocorticoid receptors. Adverse reactions are: Glaucoma with optic nerve damage, visual acuity and field defects; cataract formation; secondary ocular infection following suppression of host response; and perforation of the globe may occur; muscle weakness; osteoporosis and others. Aminoglutethimide may diminish adrenal suppression by corticosteroids. Macrolide antibiotics have been reported to cause a significant decrease in corticosteroid clearance.

DEXAMETHASONE SODIUM SUCCINATE

UZA9VMT64W

Export Data
Search for Structure

Status:

US Approved Rx (2018)

First approved in 1958

Class (Stereo):

CHEMICAL (ABSOLUTE)

Targets:

Glucocorticoid receptor

Mineralocorticoid receptor

Glucocorticoid receptor

Conditions:

Multiple myeloma

Herpes zoster keratitis

Allergic conjunctivitis

Superficial punctate keratitis

Bacterial conjunctivitis

Dexamethasone is an anti-inflammatory agent that is FDA approved for the treatment of many conditions, including rheumatic problems, a number of skin diseases, severe allergies, asthma, chronic obstructive lung disease, croup, brain swelling and othe...

rs. Dexamethasone is a glucocorticoid agonist. Unbound dexamethasone crosses cell membranes and binds with high affinity to specific cytoplasmic glucocorticoid receptors. Adverse reactions are: Glaucoma with optic nerve damage, visual acuity and field defects; cataract formation; secondary ocular infection following suppression of host response; and perforation of the globe may occur; muscle weakness; osteoporosis and others. Aminoglutethimide may diminish adrenal suppression by corticosteroids. Macrolide antibiotics have been reported to cause a significant decrease in corticosteroid clearance.

DEXAMETHASONE SUCCINATE

9UY5TBO121

Export Data
Search for Structure

Status:

US Approved Rx (2018)

First approved in 1958

Class (Stereo):

CHEMICAL (ABSOLUTE)

Targets:

Glucocorticoid receptor

Mineralocorticoid receptor

Glucocorticoid receptor

Conditions:

Multiple myeloma

Herpes zoster keratitis

Allergic conjunctivitis

Superficial punctate keratitis

Bacterial conjunctivitis

Dexamethasone is an anti-inflammatory agent that is FDA approved for the treatment of many conditions, including rheumatic problems, a number of skin diseases, severe allergies, asthma, chronic obstructive lung disease, croup, brain swelling and othe...

rs. Dexamethasone is a glucocorticoid agonist. Unbound dexamethasone crosses cell membranes and binds with high affinity to specific cytoplasmic glucocorticoid receptors. Adverse reactions are: Glaucoma with optic nerve damage, visual acuity and field defects; cataract formation; secondary ocular infection following suppression of host response; and perforation of the globe may occur; muscle weakness; osteoporosis and others. Aminoglutethimide may diminish adrenal suppression by corticosteroids. Macrolide antibiotics have been reported to cause a significant decrease in corticosteroid clearance.

DEXAMETHASONE 21-VALERATE

F2EHP3G50P

Export Data
Search for Structure

Status:

US Approved Rx (2018)

First approved in 1958

Class (Stereo):

CHEMICAL (ABSOLUTE)

Targets:

Glucocorticoid receptor

Mineralocorticoid receptor

Glucocorticoid receptor

Conditions:

Multiple myeloma

Herpes zoster keratitis

Allergic conjunctivitis

Superficial punctate keratitis

Bacterial conjunctivitis

Dexamethasone is an anti-inflammatory agent that is FDA approved for the treatment of many conditions, including rheumatic problems, a number of skin diseases, severe allergies, asthma, chronic obstructive lung disease, croup, brain swelling and othe...

rs. Dexamethasone is a glucocorticoid agonist. Unbound dexamethasone crosses cell membranes and binds with high affinity to specific cytoplasmic glucocorticoid receptors. Adverse reactions are: Glaucoma with optic nerve damage, visual acuity and field defects; cataract formation; secondary ocular infection following suppression of host response; and perforation of the globe may occur; muscle weakness; osteoporosis and others. Aminoglutethimide may diminish adrenal suppression by corticosteroids. Macrolide antibiotics have been reported to cause a significant decrease in corticosteroid clearance.

DEXAMETHASONE SODIUM SULFATE

41B47ECP9F

Export Data
Search for Structure

Status:

US Approved Rx (2018)

First approved in 1958

Class (Stereo):

CHEMICAL (ABSOLUTE)

Targets:

Glucocorticoid receptor

Mineralocorticoid receptor

Glucocorticoid receptor

Conditions:

Multiple myeloma

Herpes zoster keratitis

Allergic conjunctivitis

Superficial punctate keratitis

Bacterial conjunctivitis

Dexamethasone is an anti-inflammatory agent that is FDA approved for the treatment of many conditions, including rheumatic problems, a number of skin diseases, severe allergies, asthma, chronic obstructive lung disease, croup, brain swelling and othe...

rs. Dexamethasone is a glucocorticoid agonist. Unbound dexamethasone crosses cell membranes and binds with high affinity to specific cytoplasmic glucocorticoid receptors. Adverse reactions are: Glaucoma with optic nerve damage, visual acuity and field defects; cataract formation; secondary ocular infection following suppression of host response; and perforation of the globe may occur; muscle weakness; osteoporosis and others. Aminoglutethimide may diminish adrenal suppression by corticosteroids. Macrolide antibiotics have been reported to cause a significant decrease in corticosteroid clearance.

DEXAMETHASONE METASULFOBENZOATE

C67221CB9Q

Export Data
Search for Structure

Status:

US Approved Rx (2018)

First approved in 1958

Class (Stereo):

CHEMICAL (ABSOLUTE)

Targets:

Glucocorticoid receptor

Mineralocorticoid receptor

Glucocorticoid receptor

Conditions:

Multiple myeloma

Herpes zoster keratitis

Allergic conjunctivitis

Superficial punctate keratitis

Bacterial conjunctivitis

Dexamethasone is an anti-inflammatory agent that is FDA approved for the treatment of many conditions, including rheumatic problems, a number of skin diseases, severe allergies, asthma, chronic obstructive lung disease, croup, brain swelling and othe...

rs. Dexamethasone is a glucocorticoid agonist. Unbound dexamethasone crosses cell membranes and binds with high affinity to specific cytoplasmic glucocorticoid receptors. Adverse reactions are: Glaucoma with optic nerve damage, visual acuity and field defects; cataract formation; secondary ocular infection following suppression of host response; and perforation of the globe may occur; muscle weakness; osteoporosis and others. Aminoglutethimide may diminish adrenal suppression by corticosteroids. Macrolide antibiotics have been reported to cause a significant decrease in corticosteroid clearance.

DEXAMETHASONE 21-METHANESULFONATE

O9S11FMA79

Export Data
Search for Structure

Status:

US Approved Rx (2018)

First approved in 1958

Class (Stereo):

CHEMICAL (ABSOLUTE)

Targets:

Glucocorticoid receptor

Mineralocorticoid receptor

Glucocorticoid receptor

Conditions:

Multiple myeloma

Herpes zoster keratitis

Allergic conjunctivitis

Superficial punctate keratitis

Bacterial conjunctivitis

Dexamethasone is an anti-inflammatory agent that is FDA approved for the treatment of many conditions, including rheumatic problems, a number of skin diseases, severe allergies, asthma, chronic obstructive lung disease, croup, brain swelling and othe...

rs. Dexamethasone is a glucocorticoid agonist. Unbound dexamethasone crosses cell membranes and binds with high affinity to specific cytoplasmic glucocorticoid receptors. Adverse reactions are: Glaucoma with optic nerve damage, visual acuity and field defects; cataract formation; secondary ocular infection following suppression of host response; and perforation of the globe may occur; muscle weakness; osteoporosis and others. Aminoglutethimide may diminish adrenal suppression by corticosteroids. Macrolide antibiotics have been reported to cause a significant decrease in corticosteroid clearance.

DEXAMETHASONE DIPROPIONATE

K3UKR54YXW

Export Data
Search for Structure

Status:

US Approved Rx (2018)

First approved in 1958

Class (Stereo):

CHEMICAL (ABSOLUTE)

Targets:

Glucocorticoid receptor

Mineralocorticoid receptor

Glucocorticoid receptor

Conditions:

Multiple myeloma

Herpes zoster keratitis

Allergic conjunctivitis

Superficial punctate keratitis

Bacterial conjunctivitis

Dexamethasone is an anti-inflammatory agent that is FDA approved for the treatment of many conditions, including rheumatic problems, a number of skin diseases, severe allergies, asthma, chronic obstructive lung disease, croup, brain swelling and othe...

rs. Dexamethasone is a glucocorticoid agonist. Unbound dexamethasone crosses cell membranes and binds with high affinity to specific cytoplasmic glucocorticoid receptors. Adverse reactions are: Glaucoma with optic nerve damage, visual acuity and field defects; cataract formation; secondary ocular infection following suppression of host response; and perforation of the globe may occur; muscle weakness; osteoporosis and others. Aminoglutethimide may diminish adrenal suppression by corticosteroids. Macrolide antibiotics have been reported to cause a significant decrease in corticosteroid clearance.

Showing 1 - 10 of 43 results

First page disabled
Previous page disabled
1
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1